Corient Private Wealth
CVS icon

Corient Private Wealth’s CVS Health CVS Stock Holding History

Corient Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.5M Sell
554,868
-386,847
-41% -$29.8M 0.06% 276
2025
Q4 		$62.6M Buy
941,715
+567,251
+151% +$44.7M 0.04% 318
2025
Q3 		$28.2M Sell
374,464
-4,530
-1% -$310K 0.04% 331
2025
Q2 		$26.1M Sell
378,994
-13,376
-3% -$877K 0.03% 341
2025
Q1 		$26.6M Sell
392,370
-59,914
-13% -$3.59M 0.04% 339
2024
Q4 		$20.3M Sell
452,284
-21,913
-5% -$1.23M 0.03% 391
2024
Q3 		$29.8M Sell
474,197
-57,391
-11% -$3.35M 0.05% 341
2024
Q2 		$31.4M Sell
531,588
-213,969
-29% -$13.4M 0.05% 302
2024
Q1 		$59.5M Sell
745,557
-24,486
-3% -$1.87M 0.11% 195
2023
Q4 		$60.8M Sell
770,043
-29,710
-4% -$2.11M 0.11% 187
2023
Q3 		$55.8M Sell
799,753
-47,786
-6% -$3.39M 0.13% 171
2023
Q2 		$58.6M Buy
847,539
+165,892
+24% +$11.8M 0.14% 160
2023
Q1 		$50.7M Sell
681,647
-181,218
-21% -$15.2M 0.14% 156
2022
Q4 		$80.4M Buy
+862,865
New +$83.3M 0.29% 89

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corient Private Wealth's CVS Position: Q1 2026 in Review

Corient Private Wealth reduced its CVS Health (CVS) stake by 41% in Q1 2026, selling an estimated $29.8M and leaving 554,868 shares worth $39.5M. The position accounts for 0.06% of the portfolio, ranked #276.

Corient Private Wealth first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $80.4M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Corient Private Wealth held 554,868 shares of CVS Health worth $39.5M as of Q1 2026.
  • Corient Private Wealth sold 386,847 CVS Health shares in Q1 2026, an estimated $29.8M.
  • CVS Health made up 0.06% of Corient Private Wealth's portfolio in Q1 2026, its #276 holding.
  • Corient Private Wealth first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's CVS Health position peaked at $80.4M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.